Fundraising FoxWellington Management — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology.
BiotechDeep TechHealthtechZug, CH
Emmanuelle Charpentier(Founder)Samarth Kulkarni(Chief Executive Officer and Chairman of the Board)inJames R. Kasinger(General Counsel and Secretary)inStephen Kennedy(Head of Technical Operations)inMegan Wherry Menner(Head of Human Resources)inNaimish Patel(Chief Medical Officer)in
Co-investorsAvoro Capital AdvisorsCLI VenturesKhosla VenturesNew Enterprise Associates (NEA)SR One Capital ManagementVersant Ventures+2 more
Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG).
BiotechHealthtechCambridge, US
MICHAEL J. KAUFMAN(Executive Officer)inDonald Bergstrom(Executive Officer)inANNA PROTOPAPAS(Executive Officer, Director)Timothy Lowinger(Executive Officer)Eva Jack(Executive Officer)Wayne Foster(Executive Officer)
Co-investorsBain Capital Life SciencesF-Prime CapitalLightstone VenturesNew Enterprise Associates (NEA)Nextech InvestPfizer Venture Investments+3 more
The Trade Desk is the world's largest independent demand-side platform for media buying, serving advertisers and agencies in the digital advertising industry across 24 markets globally.
AdTechMarketing TechVentura, US
Jeff Green(Founder)inDave Pickles(Founder)inElia Videtta(Founder)Gareth Davies(Founder)Rashid Mansoor(Founder)
Co-investorsBonfire VenturesFantail VenturesFirestreak VenturesFounder CollectiveKortschak Investments L.P.SV Angel+10 more
Vuori designs and sells premium performance apparel for active consumers inspired by Coastal California lifestyle.
ConsumerDirect to ConsumerWellness & FitnessEncinitas, US
Co-investorsGeneral AtlanticNorwest Venture PartnersSoftBank Vision FundStripesThe Chernin Group (TCG Crypto)Winklevoss Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.